Jane Street
CRBP icon

Jane Street’s Corbus Pharmaceuticals CRBP Stock Holding History

Jane Street’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-373
Closed -$11K – 10147
2021
Q3 		$11K Sell
373
-37
-9% -$1.46K ﹤0.01% 9802
2021
Q2 		$23K Sell
410
-1,433
-78% -$79.5K ﹤0.01% 9626
2021
Q1 		$109K Buy
1,843
+1,186
+181% +$78K ﹤0.01% 8603
2020
Q4 		$25K Sell
657
-11,770
-95% -$440K ﹤0.01% 7361
2020
Q3 		$671K Buy
12,427
+11,890
+2,214% +$2.15M ﹤0.01% 4720
2020
Q2 		$135K Buy
+537
New +$109K ﹤0.01% 6589

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's CRBP Position: Q1 2026 in Review

Jane Street increased its Corbus Pharmaceuticals (CRBP) stake by 161% in Q1 2026, buying an estimated $380K and bringing the position to 73,193 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #7309.

Jane Street first reported a position in CRBP in Q3 2016 and has held it in 21 quarters since. The position peaked at $1.27M in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Jane Street held 73,193 shares of Corbus Pharmaceuticals worth $687K as of Q1 2026.
  • Jane Street bought 45,129 Corbus Pharmaceuticals shares in Q1 2026, an estimated $380K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7309 holding.
  • Jane Street first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 21 quarters since.
  • Jane Street's Corbus Pharmaceuticals position peaked at $1.27M in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.